Hepatitis B Alternative Medicine
Archived Posts from this Category
Complementary and Alternative Medicine Use in Chronic Liver Disease Patients.
Posted by admin on 26 Sep 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles Complementary and Alternative Medicine Use in Chronic Liver Disease Patients. J Clin Gastroenterol. 2009 Sep 23; Authors: Ferrucci LM, Bell BP, Dhotre KB, Manos MM, Terrault NA, Zaman A, Murphy RC, Vanness GR, Thomas AR, Bialek SR, Desai MM, Sofair AN GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD. PMID: 19779363 [PubMed - as supplied by publisher]
See the original post here:
Complementary and Alternative Medicine Use in Chronic Liver Disease Patients.
[Retrospective analysis of Mr. Xie Xiliang's medical records accumulated in 30 years on direct moxibustion for treating hepatitis B]
Posted by admin on 18 Aug 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles [Retrospective analysis of Mr. Xie Xiliang's medical records accumulated in 30 years on direct moxibustion for treating hepatitis B] Zhongguo Zhen Jiu. 2009 Jun;29(6):487-90 Authors: Guan L, Xiang HC, Zou Y To analyze retrospectively Mr. Xie Xiliang’s medical records accumulated in 30 years on direct moxibustion for treating hepatitis B, in which 86 cases were included. Before accepting direct moxibustion, 80.23% of the cases had been treated by conventional Chinese and western medicine, but no satisfactory therapeutic effects were obtained. Direct moxibustion was applied for 7-9 cones at each point selected. Point selection was related to ages. Usually, only a few points were used, and Ganshu (BL 18) and Pishu (BL 20) were used as main points. Shenzhu (GV 12) was added for children, and Zusanli (ST 36) added for adults. The improvement rate in clinical symptoms and physical signs were 100%. In the cases with hepatauxe, splenauxe, liver cirrhosis, and abdominal dropsy diagnozed by the B-ultrasonic examination, the improvement was obvious. Of the total, the rates turning to be negative in HBsAg, HBeAg and HBcAb were 28.85%, 38.46%, and 36.54%, respectively. It took some 10 days to 1 month to begin to show improvement in physical signs and hepetic functions, and about 3-6 months for their restoration. For the five items tested in type B hepatitis, it took 5 months to 1 year, even several years, to show their improvement. It is indicated that direct moxibustion is definitely effective in treating type B hepatitis. It is easy to handle and worth popularizing. PMID: 19563198 [PubMed - indexed for MEDLINE]
Read more from the original source:
[Retrospective analysis of Mr. Xie Xiliang's medical records accumulated in 30 years on direct moxibustion for treating hepatitis B]
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).
Posted by admin on 12 Aug 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009 Jun;3(2):323-33 Authors: Shiha G, Sarin SK, Ibrahim AE, Omata M, Kumar A, Lesmana LA, Leung N, Tozun N, Hamid S, Jafri W, Maruyama H, Bedossa P, Pinzani M, Chawla Y, Esmat G, Doss W, Elzanaty T, Sakhuja P, Nasr AM, Omar A, Wai CT, Abdallah A, Salama M, Hamed A, Yousry A, Waked I, Elsahar M, Fateen A, Mogawer S, Hamdy H, Elwakil R, Liver fibrosis is a common pathway leading to cirrhosis, which is the final result of injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, especially when treatments aimed at reversing fibrosis are being evolved. Liver biopsy has been considered to be the “gold standard” to assess fibrosis. However, liver biopsy being invasive and, in many instances, not favored by patients or physicians, alternative approaches to assess liver fibrosis have assumed great importance. Moreover, therapies aimed at reversing the liver fibrosis have also been tried lately with variable results. Till now, there has been no consensus on various clinical, pathological, and radiological aspects of liver fibrosis. The Asian Pacific Association for the Study of the Liver set up a working party on liver fibrosis in 2007, with a mandate to develop consensus guidelines on various aspects of liver fibrosis relevant to disease patterns and clinical practice in the Asia-Pacific region. The process for the development of these consensus guidelines involved the following: review of all available published literature by a core group of experts; proposal of consensus statements by the experts; discussion of the contentious issues; and unanimous approval of the consensus statements after discussion. The Oxford System of evidence-based approach was adopted for developing the consensus statements using the level of evidence from 1 (highest) to 5 (lowest) and grade of recommendation from A (strongest) to D (weakest). The consensus statements are presented in this review. PMID: 19669358 [PubMed - in process]
Here is the original:
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
Posted by rtrafaelmd on 15 Jul 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet. 2009 Jul 14; Authors: Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J To confirm and refine associations of human leukocyte antigen (HLA) genotypes with variable antibody (Ab) responses to hepatitis B vaccination, we have analyzed 255 HIV-1 seropositive (HIV(+)) youth and 80 HIV-1 seronegatives (HIV(-)) enrolled into prospective studies. In univariate analyses that focused on HLA-DRB1, -DQA1, and -DQB1 alleles and haplotypes, the DRB1*03 allele group and DRB1*0701 were negatively associated with the responder phenotype (serum Ab concentration >/= 10 mIU/mL) (P = 0.026 and 0.043, respectively). Collectively, DRB1*03 and DRB1*0701 were found in 42 (53.8%) out of 78 non-responders (serum Ab <10 mIU/mL), 65 (40.6%) out of 160 medium responders (serum Ab 10-1,000 mIU/mL), and 27 (27.8%) out of 97 high responders (serum Ab >1,000 mIU/mL) (P < 0.001 for trend). Meanwhile, DRB1*08 was positively associated with the responder phenotype (P = 0.010), mostly due to DRB1*0804 (P = 0.008). These immunogenetic relationships were all independent of non-genetic factors, including HIV-1 infection status and immunodeficiency. Alternative analyses confined to HIV(+) youth or Hispanic youth led to similar findings. In contrast, analyses of more than 80 non-coding, single nucleotide polymorphisms within and beyond the three HLA class II genes revealed no clear associations. Overall, several HLA-DRB1 alleles were major predictors of differential Ab responses to hepatitis B vaccination in youth, suggesting that T-helper cell-dependent pathways mediated through HLA class II antigen presentation are critical to effective immune response to recombinant vaccines. PMID: 19597844 [PubMed - as supplied by publisher]
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
Posted by admin on 15 Jul 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet. 2009 Jul 14; Authors: Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J To confirm and refine associations of human leukocyte antigen (HLA) genotypes with variable antibody (Ab) responses to hepatitis B vaccination, we have analyzed 255 HIV-1 seropositive (HIV(+)) youth and 80 HIV-1 seronegatives (HIV(-)) enrolled into prospective studies. In univariate analyses that focused on HLA-DRB1, -DQA1, and -DQB1 alleles and haplotypes, the DRB1*03 allele group and DRB1*0701 were negatively associated with the responder phenotype (serum Ab concentration >/= 10 mIU/mL) (P = 0.026 and 0.043, respectively). Collectively, DRB1*03 and DRB1*0701 were found in 42 (53.8%) out of 78 non-responders (serum Ab <10 mIU/mL), 65 (40.6%) out of 160 medium responders (serum Ab 10-1,000 mIU/mL), and 27 (27.8%) out of 97 high responders (serum Ab >1,000 mIU/mL) (P < 0.001 for trend). Meanwhile, DRB1*08 was positively associated with the responder phenotype (P = 0.010), mostly due to DRB1*0804 (P = 0.008). These immunogenetic relationships were all independent of non-genetic factors, including HIV-1 infection status and immunodeficiency. Alternative analyses confined to HIV(+) youth or Hispanic youth led to similar findings. In contrast, analyses of more than 80 non-coding, single nucleotide polymorphisms within and beyond the three HLA class II genes revealed no clear associations. Overall, several HLA-DRB1 alleles were major predictors of differential Ab responses to hepatitis B vaccination in youth, suggesting that T-helper cell-dependent pathways mediated through HLA class II antigen presentation are critical to effective immune response to recombinant vaccines. PMID: 19597844 [PubMed - as supplied by publisher]
Read the original post:
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
[Study on TCM syndrome typing of chronic hepatitis B]
Posted by rtrafaelmd on 21 Jun 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles [Study on TCM syndrome typing of chronic hepatitis B] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):20-3 Authors: Zhu LL, Meng H, Jiang J, et al OBJECTIVE: To explore the method for TCM syndrome typing of chronic hepatitis B (CHB).
Here is the original post:
[Study on TCM syndrome typing of chronic hepatitis B]
[Applying Fuzheng Huayu Gantang comprehensive therapeutic program for treatment of post-hepatitis B liver cirrhosis complicated with glyco-metabolic...
Posted by admin on 21 Jun 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles [Applying Fuzheng Huayu Gantang comprehensive therapeutic program for treatment of post-hepatitis B liver cirrhosis complicated with glyco-metabolic abnormality] Zhongguo Zhong Xi Yi Jie He Za Zhi.
In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
Posted by rtrafaelmd on 21 Jun 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. J Ethnopharmacol. 2008 Jun 19;118(1):148-53 Authors: Han YQ, Huang ZM, Yang XB, Liu HZ, Wu GX The traditional Chinese medicine Oenanthe javanica (OJ) has been used for many years, mainly for the treatment of inflammatory conditions including hepatitis
Read the original post:
In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
[Anthroposophic medicine: a critical analysis]
Posted by admin on 21 Jun 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles [Anthroposophic medicine: a critical analysis] MMW Fortschr Med. 2008 Apr 10;150 Suppl 1:1-6 Authors: Ernst E INTRODUCTION: Anthroposophic medicine (AM) is popular in Europe. This review is an attempt to critically evaluate the effectiveness and safety of AM.
View original here:
[Anthroposophic medicine: a critical analysis]
[Vaccines, biotechnology and their connection with induced abortion]
Posted by admin on 21 Jun 2009 | Tagged as: Hepatitis B Alternative Medicine
Related Articles [Vaccines, biotechnology and their connection with induced abortion] Cuad Bioet. 2008 May-Aug;19(66):321-53 Authors: Redondo Calderón JL Diploid cells (WI-38, MRC-5) vaccines have their origin in induced abortions.
View original post here:
[Vaccines, biotechnology and their connection with induced abortion]
